{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:30:16Z","timestamp":1768426216505,"version":"3.49.0"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T00:00:00Z","timestamp":1198195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Coeliac disease is more prevalent than was previously thought. The association between coeliac disease and cardiovascular outcome is not clear.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To investigate whether coeliac disease patients have an increased risk of cardiovascular events.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A community\u2010based cohort study using a record\u2010linkage database. Three hundred and sixty\u2010seven coeliac patients identified by a positive antiendomysial antibody test or a diagnosis with small bowel biopsy, and 5537 subjects who were tested and had a negative coeliac immunology, were included in the study.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The crude rates of cardiovascular events were 9.5 per 1000\u2003person\u2010years (95% CI: 4.4\u201314.6) in the coeliac cohort and 8.9 per 1000\u2003person\u2010years (95% CI: 7.6\u201310.3) in the antiendomysial antibody\u2010negative cohort. Compared with the antiendomysial antibody\u2010negative cohort, the adjusted relative risk of cardiovascular events for coeliac cohort was 1.9 (95% CI: 1.00\u20133.60). When we excluded patients who had previous hospitalization for cardiovascular disease, the adjusted relative risk was 2.5 (95% CI: 1.22\u20135.01). The use of any cardiovascular drugs prior to and after entry to the study were 36% and 29% for the coeliac cohort (<jats:italic>P<\/jats:italic>\u2003=\u20030.05), and 34% and 26% for the antiendomysial antibody\u2010negative cohort (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Our findings suggest that coeliac disease seems to be associated with an increased risk of cardiovascular outcome.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2007.03594.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T12:17:07Z","timestamp":1279887427000},"page":"514-519","source":"Crossref","is-referenced-by-count":64,"title":["The association between coeliac disease and cardiovascular disease"],"prefix":"10.1111","volume":"27","author":[{"given":"L.","family":"WEI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"SPIERS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"REYNOLDS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"WALSH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"FAHEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. M.","family":"MACDONALD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.02.014"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001404"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.3.320"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.7.960"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.4.518"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(02)80057-3"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.13.1566"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02008.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2004.02.014"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0398-0499(05)88207-1"},{"key":"e_1_2_6_12_2","first-page":"323","volume-title":"Pharmacoepidemiology","author":"Wei L","year":"2005"},{"key":"e_1_2_6_13_2","unstructured":"Data Quality Assurance.http:\/\/www.isdscotland.org\/isd\/4943.html(accessed on 3rd January 2008)"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta\u2010analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson SH","year":"2006","journal-title":"BMJ"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055227"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060900"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39000.486701.68"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.76.898.466"},{"key":"e_1_2_6_19_2","first-page":"140","volume-title":"Scottish Health Survey 1995, Vol. 1, Chapter 4: Smoking","author":"Turner R","year":"1997"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7119.1333"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03594.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03594.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T13:17:26Z","timestamp":1697203046000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03594.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,21]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03594.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03594.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,21]]}}}